Registration - Consultant

Idorsia Pharmaceuticals Canada Ltd / Charles Bernard, Consultant

Registration Information

Client name: Idorsia Pharmaceuticals Canada Ltd
Lobbyist name: Charles Bernard, Consultant
Initial registration start date: 2024-03-26
Registration status: Active
Registration Number: 952477-377601

Associated Communications

Total Number of Communication Reports: 2

Monthly communication reports in the last 6 months: 2

Version 2 of 2 (2024-05-14 to present)

Lobbying Information

Subject Matter Details

Details Regarding the Identified Subject Matter
Subject matters	Details	Categories
Employment and Training, Health, Science and Technology	Work to ensure sleep and Chronic Insomnia Disorder (CID) are discussed as a n essential pillar of health in Canada.	Policies or Program

Communication Techniques

Written communication
Oral communication
Grass-roots communication

The lobbyist has arranged or expects to arrange one or more meetings on behalf of the client between a public office holder and any other person in the course of this undertaking.

Government Institutions

Employment and Social Development Canada (ESDC)
Health Canada (HC)
House of Commons
Innovation, Science and Economic Development Canada (ISED)
Senate of Canada
Veterans Affairs Canada (VAC)
Women and Gender Equality (WAGE)

Client Details

Government funding

No government funding was received during the last completed financial year.

Client Contact Information

Address:
1155 Metcalfe Street
Suite 1515
Montreal, QC H3B 2V6
Canada

Telephone number: 514-770-6906
Web address: https://www.idorsia.ca/

Client representative

Mike Stamper, Head of Market Access

Parent Company Information

Idorsia Pharmaceuticals Canada Ltd is not a subsidiary of any other parent companies.

Coalition Members Information

Idorsia Pharmaceuticals Canada Ltd is not a coalition.

Individual, organization or corporation with a Direct Interest Beneficiary Information

The activities of Idorsia Pharmaceuticals Canada Ltd are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.

Subsidiary Beneficiary Information

Idorsia Pharmaceuticals Canada Ltd does not have any subsidiaries that could have a direct interest in the outcome of the undertaking

Lobbyist Details

Charles Bernard | No public offices held

Business address:
222 Queen St, Suite 1404
Ottawa, ON K1P 5V9
Canada

Telephone number: 819-674-9604

Consultant Firm and Address

Firm: Impact Public Affairs

Address:
222 Queen St, Suite 1404
Ottawa, ON K1P 5V9
Canada

Telephone number: 819-674-9604

Idorsia Pharmaceuticals Canada Ltd/

The following names have been used on or after July 2, 2008

The following names have been used on or after July 2, 2008
Name	From	To
Idorsia Pharmaceuticals Canada Ltd/	2024-05-14	current
Idorsia Pharmaceuticals Canada Ltd/	2024-03-26	2024-05-14

Idorsia Pharmaceuticals Canada Ltd

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

Charles Bernard, Impact Public Affairs (Consultant)

Learn more...

Registrants are required to submit a monthly communication report for each oral and arranged communication with a designated public office holder. The name of the most senior paid officer (i.e. the registrant) will appear on all in-house monthly communication reports, whether or not he/she participated in the communication.

Note: Monthly Communication Reports are due on the 15^th day of each month for communications that took place in the previous month.

Results below are sorted by posted date, beginning with the most recent.

Results 1-2 of 2

Idorsia Pharmaceuticals Canada Ltd
Consultant: Charles Bernard

Designated Public Office Holders who participated in the communication:
- Élisabeth Brière, Députée | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-04-09
Posted date: 2024-05-14
Communication number: 377601-603564 View associated registration
Idorsia Pharmaceuticals Canada Ltd
Consultant: Charles Bernard

Designated Public Office Holders who participated in the communication:
- Sharon Burey, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2024-04-09
Posted date: 2024-04-23
Communication number: 377601-601299 View associated registration

Charles Bernard, Impact Public Affairs (Consultant)

Learn more...

Results below are sorted by posted date, beginning with the most recent.

Results 1-2 of 2

Idorsia Pharmaceuticals Canada Ltd
Consultant: Charles Bernard

Designated Public Office Holders who participated in the communication:
- Élisabeth Brière, Députée | House of Commons
Subject Matter of the communication: Health
Communication date: 2024-04-09
Posted date: 2024-05-14
Communication number: 377601-603564 View associated registration
Idorsia Pharmaceuticals Canada Ltd
Consultant: Charles Bernard

Designated Public Office Holders who participated in the communication:
- Sharon Burey, Senator | Senate of Canada
Subject Matter of the communication: Health
Communication date: 2024-04-09
Posted date: 2024-04-23
Communication number: 377601-601299 View associated registration

Date Modified:: 2024-04-04

Search and menus

Language selection

Registration - Consultant

Idorsia Pharmaceuticals Canada Ltd / Charles Bernard, Consultant

Registration Information

Associated Communications

Version 2 of 2 (2024-05-14 to present)

Version 2 of 2 (2024-05-14 to present)

Subject Matter Details

Communication Techniques

Government Institutions

Government funding

Client Contact Information

Client representative

Parent Company Information

Coalition Members Information

Individual, organization or corporation with a Direct Interest Beneficiary Information

Subsidiary Beneficiary Information

Consultant Firm and Address